Trends in health care–associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys
暂无分享,去创建一个
G. Taylor | L. Pelude | A. McGeer | M. Science | C. Frenette | A. Simor | D. Mertz | J. Happe | Wallis Rudnick | R. Mitchell | J. Vayalumkal | C. Lavallée | Michael John | K. Suh | K. Bush | Stephanie W. Smith | L. Forrester | K. Amaratunga | D. Gravel-Tropper | S. Alexandre | A. Wong | Bonny Granfield | Stephanie Smith | Stéphanie Alexandre
[1] K. Mertens,et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis , 2019, The Lancet. Infectious diseases.
[2] M. Mulvey,et al. Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010–16 , 2018, The Journal of antimicrobial chemotherapy.
[3] R. Lynfield,et al. Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals , 2018, The New England journal of medicine.
[4] M. Taljaard,et al. The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015) , 2018, Canadian Medical Association Journal.
[5] Herman Goossens,et al. Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] D. Gravel,et al. Periprosthetic Infection following Primary Hip and Knee Arthroplasty: The Impact of Limiting the Postoperative Surveillance Period , 2016, Infection Control & Hospital Epidemiology.
[7] M. Mulvey,et al. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014 , 2016, Antimicrobial Agents and Chemotherapy.
[8] G. Gabutti,et al. Temporal trends of healthcare associated infections and antimicrobial use in 2011-2013, observed with annual point prevalence surveys in Ferrara University Hospital, Italy , 2016, Journal of preventive medicine and hygiene.
[9] D. Gravel,et al. Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys , 2016, Antimicrobial Resistance & Infection Control.
[10] M. Mulvey,et al. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012 , 2016, Infection Control & Hospital Epidemiology.
[11] P. Malani,et al. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. , 2015, JAMA.
[12] S. Berenholtz,et al. Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates” , 2014, Infection Control & Hospital Epidemiology.
[13] M. Kaouache,et al. A survey of Preventive Measures Used and their Impact on Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care Units (SPIN-BACC) , 2013, BMC Infectious Diseases.
[14] D. Gravel,et al. A point prevalence survey of health care-associated infections in Canadian pediatric inpatients. , 2012, American journal of infection control.
[15] M. Olona,et al. Prevalence of nosocomial infections in acute care hospitals in Catalonia (VINCat Program). , 2012, Enfermedades infecciosas y microbiologia clinica.
[16] D. Calfee,et al. Crisis in hospital-acquired, healthcare-associated infections. , 2012, Annual review of medicine.
[17] J. Dalton,et al. A unified approach to measuring the effect size between two groups using SAS , 2012 .
[18] J. Wille,et al. Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies. , 2010, The Journal of hospital infection.
[19] M. Loeb,et al. Methicillin-Resistant Staphylococcus aureus Colonization or Infection in Canada: National Surveillance and Changing Epidemiology, 1995–2007 , 2010, Infection Control & Hospital Epidemiology.
[20] Margaret A Dudeck,et al. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.
[21] L. Valiquette,et al. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] P. Aavitsland,et al. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. , 2005, The Journal of hospital infection.
[23] E. Ventureyra,et al. Radioisotope shuntograms at the Children’s Hospital of Eastern Ontario , 2005, Child's Nervous System.